Home LiteratureArticle Details
PMID: 9122249 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease.

Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C

Abstract

Amyloid beta peptide (A beta)-containing plaques are a hallmark of Alzheimer disease. Here, we show that the neurotoxic A beta, a major plaque component, is a potent activator of the transcription factor NF-kappaB in primary neurons. This activation required reactive oxygen intermediates as messengers because an antioxidant prevented A beta-induced NF-kappaB activation. Maximal activation of NF-kappaB was found with 0.1 microM A beta-(1-40) and 0.1 microM A beta-(25-35) fragments, making a role for NF-kappaB in neuroprotection feasible. Using an activity-specific mAb for the p65 NF-kappaB subunit, activation of NF-kappaB also was observed in neurons and astroglia of brain sections from Alzheimer disease patients. Activated NF-kappaB was restricted to cells in the close vicinity of early plaques. Our data suggest that the aberrant gene expression in diseased nervous tissue is at least in part due to A beta-induced activation of NF-kappaB, a potent immediate-early transcriptional regulator of numerous proinflammatory genes.

MeSH Terms
Alzheimer Disease/metabolism,pathology Amyloid beta-Peptides/pharmacology Animals Antioxidants/pharmacology Astrocytes/metabolism,pathology Catalase/pharmacology Cells, Cultured Cerebellum/metabolism,pathology Humans NF-kappa B/biosynthesis Neurons/drug effects,metabolism,pathology Peptide Fragments/pharmacology Proline/analogs & derivatives,pharmacology Rats Rats, Wistar Thiocarbamates/pharmacology
Chemicals
Amyloid beta-Peptides Antioxidants NF-kappa B Peptide Fragments Thiocarbamates amyloid beta-protein (1-40) amyloid beta-protein (25-35) prolinedithiocarbamate Proline Catalase
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kaltschmidt B
Institute of Biochemistry and Molecular Biology, Albert-Ludwigs-University, Freiburg, Germany. kaltschm@ruf.uni-freiburg.de
Uherek M
Volk B
Baeuerle P A
Kaltschmidt C
References (49)
49 references, click to expand
  1. Vitamin E protects nerve cells from amyloid beta protein toxicity.
    Biochem Biophys Res Commun. 1992 Jul 31;186(2):944-50 PMID: 1497677
  2. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B.
    Chem Biol. 1995 Jan;2(1):13-22 PMID: 9383399
  3. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway.
    Science. 1993 Mar 26;259(5103):1912-5 PMID: 8096091
  4. H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor.
    EMBO J. 1993 May;12(5):2005-15 PMID: 8491191
  5. Amyloid beta-protein activates tachykinin receptors and inositol trisphosphate accumulation by synergy with glutamate.
    Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7508-12 PMID: 7689220
  6. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B.
    Nature. 1993 Sep 9;365(6442):182-5 PMID: 8371761
  7. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.
    Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10061-5 PMID: 7694279
  8. Oxidative stress, glutamate, and neurodegenerative disorders.
    Science. 1993 Oct 29;262(5134):689-95 PMID: 7901908
  9. Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer's disease.
    Am J Pathol. 1994 Jan;144(1):104-16 PMID: 7904796
  10. Localization of Alzheimer beta A4 amyloid precursor protein at central and peripheral synaptic sites.
    Brain Res. 1991 Nov 1;563(1-2):184-94 PMID: 1786532
  11. Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-kappa B-like nuclear protein.
    J Neuroimmunol. 1992 Aug;39(3):231-42 PMID: 1644898
  12. Brain synapses contain inducible forms of the transcription factor NF-kappa B.
    Mech Dev. 1993 Oct;43(2-3):135-47 PMID: 8297787
  13. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.
    Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3270-4 PMID: 8159737
  14. Constitutive NF-kappa B activity in neurons.
    Mol Cell Biol. 1994 Jun;14(6):3981-92 PMID: 8196637
  15. Hydrogen peroxide mediates amyloid beta protein toxicity.
    Cell. 1994 Jun 17;77(6):817-27 PMID: 8004671
  16. Function and activation of NF-kappa B in the immune system.
    Annu Rev Immunol. 1994;12:141-79 PMID: 8011280
  17. Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation.
    Mol Cell Biol. 1994 Aug;14(8):5349-59 PMID: 8035813
  18. Inflammatory mechanisms in Alzheimer's disease: implications for therapy.
    Am J Psychiatry. 1994 Aug;151(8):1105-13 PMID: 7518651
  19. Expression of inducible nitric oxide synthase by neurones following exposure to endotoxin and cytokine.
    Br J Pharmacol. 1994 Jul;112(3):720-2 PMID: 7522856
  20. Transcription factor NF-kappa B is activated in microglia during experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 1994 Nov;55(1):99-106 PMID: 7962486
  21. Behavioral and anatomical deficits in mice homozygous for a modified beta-amyloid precursor protein gene.
    Cell. 1994 Dec 2;79(5):755-65 PMID: 8001115
  22. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
    Nature. 1995 Feb 9;373(6514):523-7 PMID: 7845465
  23. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.
    J Neuropathol Exp Neurol. 1995 Mar;54(2):276-81 PMID: 7876895
  24. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ.
    Acta Neuropathol. 1995;89(1):35-41 PMID: 7709729
  25. beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity.
    Cell. 1995 May 19;81(4):525-31 PMID: 7758106
  26. Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures.
    Neurosci Lett. 1995 Mar 16;188(1):70-4 PMID: 7783982
  27. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.
    Nature. 1995 Jul 13;376(6536):167-70 PMID: 7603567
  28. Selective recognition of the activated form of transcription factor NF-kappa B by a monoclonal antibody.
    Biol Chem Hoppe Seyler. 1995 Jan;376(1):9-16 PMID: 7612189
  29. Induction of MHC class I genes in neurons.
    Science. 1995 Jul 28;269(5223):549-52 PMID: 7624779
  30. Glial cytokines in Alzheimer's disease: review and pathogenic implications.
    Hum Pathol. 1995 Aug;26(8):816-23 PMID: 7635444
  31. Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons.
    Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9618-22 PMID: 7568184
  32. Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro.
    Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9077-81 PMID: 7568076
  33. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.
    Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9328-32 PMID: 7568127
  34. Identification and characterization of a kappa B/Rel binding site in the regulatory region of the amyloid precursor protein gene.
    J Biol Chem. 1995 Nov 10;270(45):26774-7 PMID: 7592914
  35. Induction of oxidative stress by okadaic acid is required for activation of transcription factor NF-kappa B.
    J Biol Chem. 1995 Nov 10;270(45):27136-42 PMID: 7592968
  36. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.
    Biochem Biophys Res Commun. 1984 May 16;120(3):885-90 PMID: 6375662
  37. Amyloid plaque core protein in Alzheimer disease and Down syndrome.
    Proc Natl Acad Sci U S A. 1985 Jun;82(12):4245-9 PMID: 3159021
  38. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.
    Nature. 1987 Feb 19-25;325(6106):733-6 PMID: 2881207
  39. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.
    Science. 1990 Oct 12;250(4978):279-82 PMID: 2218531
  40. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus.
    Proc Natl Acad Sci U S A. 1990 Dec;87(24):9943-7 PMID: 2263644
  41. Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage.
    Brain Res. 1990 Nov 19;533(2):315-20 PMID: 2289145
  42. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1.
    EMBO J. 1991 Aug;10(8):2247-58 PMID: 2065663
  43. Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?
    Immunol Today. 1991 Jul;12(7):217-9 PMID: 1909530
  44. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients.
    Lab Invest. 1992 Feb;66(2):223-30 PMID: 1370967
  45. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
    Genes Dev. 1995 Nov 15;9(22):2723-35 PMID: 7590248
  46. Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75.
    Science. 1996 Apr 26;272(5261):542-5 PMID: 8614802
  47. TrkA activation is sufficient to rescue axotomized cholinergic neurons.
    Neuron. 1996 Mar;16(3):653-63 PMID: 8785062
  48. Generation of mice with a 200-kb amyloid precursor protein gene deletion by Cre recombinase-mediated site-specific recombination in embryonic stem cells.
    Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6158-62 PMID: 8650236
  49. The NF-kappa B p65 promoter.
    J Acquir Immune Defic Syndr. 1993 Mar;6(3):227-30 PMID: 8450395
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1997-03-18
Pages
2642-7
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC20142
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com